Cargando…
An observational study of adult admissions to a medical ICU due to adverse drug events
BACKGROUND: The objectives of the study were to estimate the incidence of intensive care unit (ICU) admissions due to adverse drug events (ADEs), to assess preventability, severity and costs of the corresponding ADE and to determine the leading causes of preventable ADEs. METHODS: An observational s...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Paris
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735088/ https://www.ncbi.nlm.nih.gov/pubmed/26830112 http://dx.doi.org/10.1186/s13613-016-0109-9 |
_version_ | 1782413014619652096 |
---|---|
author | Jolivot, Pierre-Alain Pichereau, Claire Hindlet, Patrick Hejblum, Gilles Bigé, Naïke Maury, Eric Guidet, Bertrand Fernandez, Christine |
author_facet | Jolivot, Pierre-Alain Pichereau, Claire Hindlet, Patrick Hejblum, Gilles Bigé, Naïke Maury, Eric Guidet, Bertrand Fernandez, Christine |
author_sort | Jolivot, Pierre-Alain |
collection | PubMed |
description | BACKGROUND: The objectives of the study were to estimate the incidence of intensive care unit (ICU) admissions due to adverse drug events (ADEs), to assess preventability, severity and costs of the corresponding ADE and to determine the leading causes of preventable ADEs. METHODS: An observational study was conducted in a medical ICU of a teaching hospital from February 2013 to February 2014. RESULTS: A total of 743 consecutive admissions were included, and they involved 701 different patients. The included admissions were categorized into three groups (admissions due to preventable ADE, admissions due to unpreventable ADE and the control group). Among the 743 ICU admissions included during the study period, 173 (23.3 %) were due to ADE, with 102 (13.7 %) related to preventable ADE and 71 (9.6 %) to unpreventable ADE, yielding a preventability rate of ADE of 0.59 (102/173). Admissions due to unpreventable ADE concerned patients with more comorbidities, a greater number of drugs and higher Simplified Acute Physiology Score II than admissions due to preventable ADE and the control group admissions (n = 570). Hospital mortality rates, corresponding costs and length of stay were all similar in the preventable ADE and control groups, whereas they were always significantly higher in the unpreventable ADE group. ICU mortality, length of stay and the corresponding costs were similar in the three groups. Non-compliance was the principal leading cause of preventable ADE (n = 31/102). The 102 preventable ADE-related admissions accounted for a total of 528 days of hospitalization in the ICU, requiring a mean of 1.4 ICU beds per day over the one-year period, with an associated total cost amounting to 747,651 €. CONCLUSIONS: ADE was a major cause of admission in the studied ICU, and in 59 % of the cases, ADEs were preventable. The reported burden of ICU admissions due to ADE advocates for further investigations to explore how the rate of such admissions could be decreased. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13613-016-0109-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4735088 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Paris |
record_format | MEDLINE/PubMed |
spelling | pubmed-47350882016-02-12 An observational study of adult admissions to a medical ICU due to adverse drug events Jolivot, Pierre-Alain Pichereau, Claire Hindlet, Patrick Hejblum, Gilles Bigé, Naïke Maury, Eric Guidet, Bertrand Fernandez, Christine Ann Intensive Care Research BACKGROUND: The objectives of the study were to estimate the incidence of intensive care unit (ICU) admissions due to adverse drug events (ADEs), to assess preventability, severity and costs of the corresponding ADE and to determine the leading causes of preventable ADEs. METHODS: An observational study was conducted in a medical ICU of a teaching hospital from February 2013 to February 2014. RESULTS: A total of 743 consecutive admissions were included, and they involved 701 different patients. The included admissions were categorized into three groups (admissions due to preventable ADE, admissions due to unpreventable ADE and the control group). Among the 743 ICU admissions included during the study period, 173 (23.3 %) were due to ADE, with 102 (13.7 %) related to preventable ADE and 71 (9.6 %) to unpreventable ADE, yielding a preventability rate of ADE of 0.59 (102/173). Admissions due to unpreventable ADE concerned patients with more comorbidities, a greater number of drugs and higher Simplified Acute Physiology Score II than admissions due to preventable ADE and the control group admissions (n = 570). Hospital mortality rates, corresponding costs and length of stay were all similar in the preventable ADE and control groups, whereas they were always significantly higher in the unpreventable ADE group. ICU mortality, length of stay and the corresponding costs were similar in the three groups. Non-compliance was the principal leading cause of preventable ADE (n = 31/102). The 102 preventable ADE-related admissions accounted for a total of 528 days of hospitalization in the ICU, requiring a mean of 1.4 ICU beds per day over the one-year period, with an associated total cost amounting to 747,651 €. CONCLUSIONS: ADE was a major cause of admission in the studied ICU, and in 59 % of the cases, ADEs were preventable. The reported burden of ICU admissions due to ADE advocates for further investigations to explore how the rate of such admissions could be decreased. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13613-016-0109-9) contains supplementary material, which is available to authorized users. Springer Paris 2016-02-02 /pmc/articles/PMC4735088/ /pubmed/26830112 http://dx.doi.org/10.1186/s13613-016-0109-9 Text en © Jolivot et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Jolivot, Pierre-Alain Pichereau, Claire Hindlet, Patrick Hejblum, Gilles Bigé, Naïke Maury, Eric Guidet, Bertrand Fernandez, Christine An observational study of adult admissions to a medical ICU due to adverse drug events |
title | An observational study of adult admissions to a medical ICU due to adverse drug events |
title_full | An observational study of adult admissions to a medical ICU due to adverse drug events |
title_fullStr | An observational study of adult admissions to a medical ICU due to adverse drug events |
title_full_unstemmed | An observational study of adult admissions to a medical ICU due to adverse drug events |
title_short | An observational study of adult admissions to a medical ICU due to adverse drug events |
title_sort | observational study of adult admissions to a medical icu due to adverse drug events |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735088/ https://www.ncbi.nlm.nih.gov/pubmed/26830112 http://dx.doi.org/10.1186/s13613-016-0109-9 |
work_keys_str_mv | AT jolivotpierrealain anobservationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents AT pichereauclaire anobservationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents AT hindletpatrick anobservationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents AT hejblumgilles anobservationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents AT bigenaike anobservationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents AT mauryeric anobservationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents AT guidetbertrand anobservationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents AT fernandezchristine anobservationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents AT jolivotpierrealain observationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents AT pichereauclaire observationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents AT hindletpatrick observationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents AT hejblumgilles observationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents AT bigenaike observationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents AT mauryeric observationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents AT guidetbertrand observationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents AT fernandezchristine observationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents |